Knopman DS - Search Results

1

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.

Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Pankratz VS, Donohue MC, Trojanowski JQ. Jack CR Jr, et al. Among authors: knopman ds. Lancet Neurol. 2013 Feb;12(2):207-16. doi: 10.1016/S1474-4422(12)70291-0. Lancet Neurol. 2013. PMID: 23332364 Free PMC article.

2

A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group.

Thal LJ, Schwartz G, Sano M, Weiner M, Knopman D, Harrell L, Bodenheimer S, Rossor M, Philpot M, Schor J, Goldberg A. Thal LJ, et al. Neurology. 1996 Dec;47(6):1389-95. doi: 10.1212/wnl.47.6.1389. Neurology. 1996. PMID: 8960716 Clinical Trial.

3

Cardiovascular risk factors and cognitive decline in middle-aged adults.

Knopman D, Boland LL, Mosley T, Howard G, Liao D, Szklo M, McGovern P, Folsom AR; Atherosclerosis Risk in Communities (ARIC) Study Investigators. Knopman D, et al. Neurology. 2001 Jan 9;56(1):42-8. doi: 10.1212/wnl.56.1.42. Neurology. 2001. PMID: 11148234

4

A videotaped CIBIC for dementia patients: validity and reliability in a simulated clinical trial.

Quinn J, Moore M, Benson DF, Clark CM, Doody R, Jagust W, Knopman D, Kaye JA. Quinn J, et al. Neurology. 2002 Feb 12;58(3):433-7. doi: 10.1212/wnl.58.3.433. Neurology. 2002. PMID: 11839844 Clinical Trial.

5

Pharmacotheraphy for Alzheimer's disease.

Knopman D. Knopman D. Curr Neurol Neurosci Rep. 2001 Sep;1(5):428-34. doi: 10.1007/s11910-001-0102-y. Curr Neurol Neurosci Rep. 2001. PMID: 11898553 Review.

6

1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease.

Kantarci K, Smith GE, Ivnik RJ, Petersen RC, Boeve BF, Knopman DS, Tangalos EG, Jack CR Jr. Kantarci K, et al. Among authors: knopman ds. J Int Neuropsychol Soc. 2002 Nov;8(7):934-42. doi: 10.1017/s1355617702870084. J Int Neuropsychol Soc. 2002. PMID: 12405545 Free PMC article.

7

MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.

Jack CR Jr, Slomkowski M, Gracon S, Hoover TM, Felmlee JP, Stewart K, Xu Y, Shiung M, O'Brien PC, Cha R, Knopman D, Petersen RC. Jack CR Jr, et al. Neurology. 2003 Jan 28;60(2):253-60. doi: 10.1212/01.wnl.0000042480.86872.03. Neurology. 2003. PMID: 12552040 Free PMC article. Clinical Trial.

8

Mild cognitive impairment in the oldest old.

Boeve B, McCormick J, Smith G, Ferman T, Rummans T, Carpenter T, Ivnik R, Kokmen E, Tangalos E, Edland S, Knopman D, Petersen R. Boeve B, et al. Neurology. 2003 Feb 11;60(3):477-80. doi: 10.1212/wnl.60.3.477. Neurology. 2003. PMID: 12578930

9

Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T.

Kantarci K, Reynolds G, Petersen RC, Boeve BF, Knopman DS, Edland SD, Smith GE, Ivnik RJ, Tangalos EG, Jack CR Jr. Kantarci K, et al. Among authors: knopman ds. AJNR Am J Neuroradiol. 2003 May;24(5):843-9. AJNR Am J Neuroradiol. 2003. PMID: 12748083 Free PMC article.

10

Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism.

Boeve BF, Silber MH, Parisi JE, Dickson DW, Ferman TJ, Benarroch EE, Schmeichel AM, Smith GE, Petersen RC, Ahlskog JE, Matsumoto JY, Knopman DS, Schenck CH, Mahowald MW. Boeve BF, et al. Among authors: knopman ds. Neurology. 2003 Jul 8;61(1):40-5. doi: 10.1212/01.wnl.0000073619.94467.b0. Neurology. 2003. PMID: 12847154

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,075 results

Search Page